What happened in the Cell and Gene Therapy sector in 2017, and what should we be looking out for in 2018? Over 500 executives, investors, scientists and patient advocates gathered together yesterday to find out at the Alliance for Regenerative Medicine (ARM) State of the Industry Briefing in San Francisco, California. ARM Chairman, Robert Preti, … Continue reading Recap of the 2018 Alliance for Regenerative Medicine Cell and Gene Therapy State of the Industry
gene therapy
Stem cell and gene therapy research gets a good report card from industry leader
The state of the regenerative medicine field is strong and getting stronger. That was the bottom line verdict at the 2017 Cell and Gene Therapies State of the Industry briefing in San Francisco. The briefing, an annual update on the field presented by the Alliance for Regenerative Medicine (ARM), gave a “by the numbers” look … Continue reading Stem cell and gene therapy research gets a good report card from industry leader
Key Steps Along the Way To Finding Treatments for HIV on World AIDS Day
Today, December 1st, is World AIDS Day. It's a day to acknowledge the progress that is being made in HIV prevention and treatment around the world but also to renew our commitment to a future free of HIV. This year's theme is Leadership. Commitment. Impact. At CIRM we are funding a number of projects focused … Continue reading Key Steps Along the Way To Finding Treatments for HIV on World AIDS Day
What Went Down at ARM’s Regenerative Medicine State of the Industry
Every January, downtown San Francisco is taken over by a flock of investors, bankers, biotech companies, and scientists attending the annual JP Morgan Healthcare Conference. This meeting looks at the healthcare advancements over the past year and predicts the disease areas and technologies that will see the most progress and success in 2016. According to … Continue reading What Went Down at ARM’s Regenerative Medicine State of the Industry
While You Were Away: Gene Editing Treats Mice with Duchenne Muscular Dystrophy
Welcome back everyone! I hope you enjoyed your holiday and are looking forward to an exciting new year. My favorite thing about coming back from vacation is to see what cool new science was published. Because as you know, science doesn’t take a vacation! As I was reading over the news for this past week, … Continue reading While You Were Away: Gene Editing Treats Mice with Duchenne Muscular Dystrophy
HIV/AIDS: Progress and Promise of Stem Cell Research
Our friends at Americans for Cures and Youreka Science have done it again. They’ve produced another whiteboard video about the progress and promise of stem cell research that’s so inspiring that it would probably make Darth Vader consider coming back to the light side. This time they tackled HIV. If you haven’t watched one of … Continue reading HIV/AIDS: Progress and Promise of Stem Cell Research
Cell mate: the man who makes stem cells for clinical trials
When we announced that one of the researchers we fund - Dr. Henry Klassen at the University of California, Irvine - has begun his clinical trial to treat the vision-destroying disease retinitis pigmentosa, we celebrated the excitement felt by the researchers and the hope from people with the disease. But we missed out one group. … Continue reading Cell mate: the man who makes stem cells for clinical trials
Gene Therapy Beats Half-Matched Stem Cell Transplant in Side-by-Side Comparison to Treat ‘Bubble Baby’ Disease
If you are born with Severe Combined Immunodeficiency (SCID), your childhood is anything but normal. You don’t get to play with other kids, or be held by your parents. You can’t even breathe the same air. And, without treatment, you probably won’t live past your first year. This is the reality of SCID, also called … Continue reading Gene Therapy Beats Half-Matched Stem Cell Transplant in Side-by-Side Comparison to Treat ‘Bubble Baby’ Disease
One-Time, Lasting Treatment for Sickle Cell Disease May be on Horizon, According to New CIRM-Funded Study
For the nearly 1,000 babies born each year in the United States with sickle cell disease, a painful and arduous road awaits them. The only cure is to find a bone marrow donor—an exceedingly rare proposition. Instead, the standard treatment for this inherited blood disorder is regular blood transfusions, with repeated hospitalizations to deal with … Continue reading One-Time, Lasting Treatment for Sickle Cell Disease May be on Horizon, According to New CIRM-Funded Study